Success Metrics

Clinical Success Rate
83.1%

Based on 69 completed trials

Completion Rate
83%(69/83)
Active Trials
17(11%)
Results Posted
25%(17 trials)
Terminated
14(9%)

Phase Distribution

Ph not_applicable
55
36%
Ph phase_1
12
8%
Ph phase_2
36
24%
Ph phase_3
20
13%
Ph early_phase_1
2
1%
Ph phase_4
17
11%

Phase Distribution

14

Early Stage

36

Mid Stage

37

Late Stage

Phase Distribution142 total trials
Early Phase 1First-in-human
2(1.4%)
Phase 1Safety & dosage
12(8.5%)
Phase 2Efficacy & side effects
36(25.4%)
Phase 3Large-scale testing
20(14.1%)
Phase 4Post-market surveillance
17(12.0%)
N/ANon-phased studies
55(38.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

69 of 92 finished

Non-Completion Rate

25.0%

23 ended early

Currently Active

17

trials recruiting

Total Trials

151

all time

Status Distribution
Active(25)
Completed(69)
Terminated(23)
Other(34)

Detailed Status

Completed69
unknown34
Terminated14
Recruiting14
Withdrawn9
Not yet recruiting7

Development Timeline

Analytics

Development Status

Total Trials
151
Active
17
Success Rate
83.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.4%)
Phase 112 (8.5%)
Phase 236 (25.4%)
Phase 320 (14.1%)
Phase 417 (12.0%)
N/A55 (38.7%)

Trials by Status

terminated149%
unknown3423%
withdrawn96%
completed6946%
enrolling_by_invitation11%
not_yet_recruiting75%
active_not_recruiting32%
recruiting149%

Recent Activity

Clinical Trials (151)

Showing 20 of 151 trialsScroll for more
NCT07700615Phase 4

Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults

Completed
NCT07702669Not Applicable

Modified Huanglian Wendan Decoction for Metabolic Syndrome

Completed
NCT07671508Phase 2

Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases

Completed
NCT04573751Not Applicable

The EPIVER Randomized Controlled Trial

Completed
NCT07657208Not Applicable

Effects of Snoezelen Multisensory Therapy on Older Adults With Dementia

Completed
NCT00929214Phase 2

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Active Not Recruiting
NCT07214818Phase 2

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Recruiting
NCT04992910Not Applicable

Multi-field Functional Electrical Stimulation for Distal Upper-limb Rehabilitation After Subacute Stroke: a Pilot Randomised Controlled Trial

Completed
NCT07606703Phase 2

A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT

Recruiting
NCT06950294Early Phase 1

iNO300 Therapy in Critically Ill Patients With Pneumonia

Recruiting
NCT07580365Not Applicable

VirtualPark_Pediatric

Not Yet Recruiting
NCT04908865Phase 4

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Completed
NCT01042379Phase 2

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Recruiting
NCT06297096Phase 3

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Recruiting
NCT04314687Phase 1

Stem Cell and Conditioned Medium for Cerebral Palsy

Active Not Recruiting
NCT07349836Early Phase 1

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Not Yet Recruiting
NCT07342088Not Applicable

Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in Children

Completed
NCT07327710Not Applicable

Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy

Enrolling By Invitation
NCT07242222Phase 1

Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease

Recruiting
NCT07238985Phase 1

Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
151